On May 16, 2022 infant formula maker Abbott says it's reached an agreement with U.S. health officials to restart production at its largest domestic factory.
U.S. medical authorities are revisiting the safety of breast implants used by millions of American women, the latest review in an ongoing debate about their potential health effects.